G**********n
发帖数: 973 | 1 Pfizer's Puzzle
Its stock is off 40% since 2001. Profits are down. CEO Hank McKinnell's to-
do list? Create hit drugs, pick a successor, and convince Wall Street he can
make all the company's pieces fit together.
ByJohn Simons, FORTUNE Magazine
April 13, 2006: 11:48 AM EDT
(FORTUNE Magazine) - IS Hank McKinnell a failure? A success? Or something in
between? Those are the questions people in and out of Pfizer are pondering
as its CEO enters his final years on the job.
Everyone certainly agrees th | i****f
发帖数: 473 | 2 Pharm industry is like no other, cannot predict it using standards of other
industries like motor, semi-conduct, etc.
-
can
in
pondering
【在 G**********n 的大作中提到】
: Pfizer's Puzzle
: Its stock is off 40% since 2001. Profits are down. CEO Hank McKinnell's to-
: do list? Create hit drugs, pick a successor, and convince Wall Street he can
: make all the company's pieces fit together.
: ByJohn Simons, FORTUNE Magazine
: April 13, 2006: 11:48 AM EDT
: (FORTUNE Magazine) - IS Hank McKinnell a failure? A success? Or something in
: between? Those are the questions people in and out of Pfizer are pondering
: as its CEO enters his final years on the job.
: Everyone certainly agrees th
| U******m
发帖数: 423 | 3 Pfizer will be the biggest loser in the pharma world if nothing happens. | a*******o
发帖数: 280 | 4 old
Hank is gone already
-
can
in
pondering
【在 G**********n 的大作中提到】
: Pfizer's Puzzle
: Its stock is off 40% since 2001. Profits are down. CEO Hank McKinnell's to-
: do list? Create hit drugs, pick a successor, and convince Wall Street he can
: make all the company's pieces fit together.
: ByJohn Simons, FORTUNE Magazine
: April 13, 2006: 11:48 AM EDT
: (FORTUNE Magazine) - IS Hank McKinnell a failure? A success? Or something in
: between? Those are the questions people in and out of Pfizer are pondering
: as its CEO enters his final years on the job.
: Everyone certainly agrees th
| G**********n
发帖数: 973 | | g********n
发帖数: 4054 | 6 I see.
NEW YORK, Aug 15 (Reuters) - Pfizer Inc. said on Tuesday its head of
pharmaceutical operations, Karen Katen, who failed in a contest last month
to become chief executive of the world's largest drugmaker, would leave in
the coming months.
Katen had been among three internal candidates to replace former CEO Hank
McKinnell. But she and another vice chairman, David Shedlarz, were passed
over for the post when the board chose Jeff Kindler, a third vice chairman
and general counsel.
【在 a*******o 的大作中提到】
: old
: Hank is gone already
:
: -
: can
: in
: pondering
|
|
